SWOT analysis

October 20-21 2016Istituto Superiore di Sanità, Rome

Angela GiustiNational Institute of Health, Italy

WP7 Final MeetingDiabetes: a case study on strengthening health care for people

with chronic diseases

WWW.CHRODIS.EU

DisclosuresHealth Industry Interests Relevant to Presentation

Angela Giusti

1 – Patent holder/Shareholder or member or employee of a health industry NO

2 – Consultant or member of a scientific council of a health industry NO

3 – Paid speaker or author/editor of articles or documents for a health industry NO

4 – Payment of travel expenses, lodging, or conference/event registration by a

health industryNO

5 – Principal Investigator of a research or clinical study for a health industry NO

6 – Co-Investigator of a clinical study for a health industry NO

WWW.CHRODIS.EU

Rationale

The challenge facing decision-makers and

leaders in health care

• how to strengthen chronic disease

prevention and control efforts

• how to re-design health care system to

better meet complex needs of persons with

chronic diseases

In the frame of the JA-CHRODIS, diabetes is

considered a case study on strengthening

health care for people with chronic diseases.

WWW.CHRODIS.EU

Objective

The aim of the WP7 SWOT analysis is

• to give a qualitative overview of the national policie s and programs on prevention and management of diabetes across Europe

• to offer insights on what makes a policy/program

APPLICABLE SUSTAINABLE EFFECTIVE

from a public health and from the stakeholders perspectives

• the basic preconditions for its implementation

• the successful strategies and lesson learnt from the experience

WWW.CHRODIS.EU

Methods

Used for

� analysis of Strengths, Weaknesses,

Opportunities, and Threats of a

project, an intervention, a program or

a policy

� strategic planning, to outline the

key internal and external factors that

can influence the success

• Developed in the area of business

and industry

• Extensively used in community

development programs, health

and education

• Participatory, simple, applicable

to different contexts and levels of

analysis, including policies and

programs, implementation and

evaluation

The SWOT analysis

WWW.CHRODIS.EU

Internal

They fall within the scope and

control of the program

External

Conditions that are outside the

direct control of the program

SWOT analysis: the structure

WWW.CHRODIS.EU

Data collection

Key responders

identified by

Task Leaders and

Chrodis-JA Partners

Select up to 5

relevant policies or

programs per

Country

WWW.CHRODIS.EU

� Planning � Endorsement by policy makers and stakeholders � Implementation �

Organizational changes � Partnerships � Multi, inter or transectorality � Management

� Human resources � Technology and information systems � Coordination of care (i.e.

multi or interdisciplinarity) � Funding � Integration with other policies/programs �

Supported by laws or regulations � Leadership � Empowerment � Capacity building �

� Monitoring and evaluation � Internal and external communication �

Data collection

Select up to 5

relevant policies or

programs per

Country

Analyse according to

relevant dimensions

WWW.CHRODIS.EU

Data collection

Select up to 5

relevant policies or

programs per

Country

Analyse according to

relevant dimensionsOutput

One comprehensive

SWOT per Country

12 + 2 SWOT

reporting and analysing

44 policies

Data analysisCoding, cathegorial analysis

(Nvivo 10.0)

WWW.CHRODIS.EU

Results

N. stakeholders involved 57

N. policies included 44

Methods of participation:

email, face-to-face meeting,

group video call, individual call

Countries contributing to the SWOT

WWW.CHRODIS.EU

Policies&programs on diabetes across Europe: challenges and potentials

WWW.CHRODIS.EU

Policies&programs on diabetes across Europe: challenges and potentials

WWW.CHRODIS.EU

Key messages

WWW.CHRODIS.EU

“Integration at local level

will need many facilitators

– NDP should develop its

mobilizing power”

When planning, implementing a policy or a program on NCD, let’s keep in mind …

“Continuous

lobbying of

decision-makers

and politicians is

mandatory”

“The program reduces

its impact and

credibility when there

is no long term

budget linked to it”

“Health-care

professionals want to

do their best – give

them an opportunity to

improve and they will

grasp it”

“Proactive

professionals and

patients’

organizations may

lead the process”

“Most of the daily

decisions in relation

to treatment are

made by the patients

at home”

“All changes take time

and resources (more

than anticipated)”

“Go out from

healthcare

system”

WWW.CHRODIS.EU

Conclusions

• The whole of these considerations, thoughts,

experiences and insights draws an overall picture

of the complexity, challenges and potentials when

designing and implementing good policies and

programs.

• These results may apply to any context across

Europe, and may be used by decision makers,

managers, professionals and other stakeholders to

focus on key-issues, recognizing areas for

attention.

WWW.CHRODIS.EU

Thanks to our partners and experts

Austria - Brigitte Domittner, Sabine Weissenhofer (GÖG). Ilana Ventura, Robert Moschitz, Petra Lehner, Stephanie Stürzenbecher, Gerhard Hofer, Eva Kernstock, Robert Griebler.Belgium - Valentina Strammiello (EPF). Mayur Mandalia (IDF Europe). Viviane de Laveleye, Stijn de Ceukelier. Finland - Jaana Lindström, Katja Wikström (THL). Auli Pölönen, Heikki Oksa. France - Alain Brunot (MoH) Germany - Andrea Icks, Ulrike Rothe Greece - Theodore Vontetsianos (YPE) Italy - Marina Maggini, Angela Giusti, Bruno Caffari, Flavia Lombardo, Flavia Pricci (ISS), Massimo Massi Benedetti (HIRS), Roberto D'Elia, Paola Pisanti (MINSAL). Albino Bottazzo, Rita Stara Lithuania - Zydrune Visockiene (VUKSK) Norway - Monica Sørensen (HOD) Portugal - José Manuel Boavida, Cristina Portugal (DGS) Slovenia - Jelka Zaletel (NIJZ) Spain - Vendula Blaya Nováková, María del Mar Polo de Santos, Antonio Sarría Santamera (ISCIII) EIWH - Peggy Maguire, Maeve Cusack, Vanessa Maria Moore EWMA - Alberto Piaggesi, Jan Apelqvist, Kristien van Acker

WWW.CHRODIS.EU

The Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS)*

* This presentation arises from the Joint Action onChronic Diseases and Promoting Healthy Ageing acrossthe Life Cycle (JA-CHRODIS), which has receivedfunding from the European Union, in the framework ofthe Health Programme (2008-2013). Sole responsibilitylies with the author and the Consumers, Health,Agriculture and Food Executive Agency is notresponsible for any use that may be made of theinformation contained therein.